Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae.
about
Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trialsSingle-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomized clinical trial.treatment and prevention of otitis media.A Randomized, Double-blinded, Open Label Study of the Efficacy and Safety of Cefcapene Pivoxil and Amoxicillin·Clavulanate in Acute Presumed Bacterial Rhinosinusitis.Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media.In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.
P2860
Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Safety and tolerability of a n ...... tant Streptococcus pneumoniae.
@en
Safety and tolerability of a new formulation
@nl
type
label
Safety and tolerability of a n ...... tant Streptococcus pneumoniae.
@en
Safety and tolerability of a new formulation
@nl
prefLabel
Safety and tolerability of a n ...... tant Streptococcus pneumoniae.
@en
Safety and tolerability of a new formulation
@nl
P2093
P1476
Safety and tolerability of a n ...... tant Streptococcus pneumoniae.
@en
P2093
Bottenfield GW
Hedrick JA
Rowinski CA
P304
P356
10.1097/00006454-199810000-00041
P577
1998-10-01T00:00:00Z